title: Estrogen-mediated Height Control in Girls with Marfan Syndrome.
abstract: This study evaluated the efficacy of a stepwise regimen of estradiol valerate for height control in girls with Marfan syndrome. Eight girls with Marfan syndrome who had completed estrogen treatment for height control were included. Estradiol valerate was started at a dose of 2 mg/day, and then was increased. The projected final height was estimated using the initial height percentile (on a disease-specific growth curve for Korean Marfan syndrome [gcPFHt]), and the initial bone age (baPFHt). After the estrogen treatment, the projected final height was compared to the actual final height (FHt). The median baseline chronological and bone age were 10.0 and 10.5 years, respectively. After a median of 36.5 months of treatment, the median FHt (172.6 cm) was shorter than the median gcPFHt (181.0 cm) and baPFHt (175.9 cm). In the six patients who started treatment before the age of 11 years, the median FHt (171.8 cm) was shorter than the median gcPFHt (181.5 cm) and baPFHt (177.4 cm) after treatment. The median differences between the FHt and gcPFHt and baPFHt were 9.2 and 8.3 cm, respectively. In two patients started treatment after the age of 11, the differences between FHt and gcPFHt, and baPFHt after treatment were -4 and 1.4 cm, and -1.2 and 0 cm for each case, respectively. A stepwise increasing regimen of estradiol valerate may be an effective treatment for height control in girls with Marfan syndrome, especially when started under 11 years old.
authors.affiliation: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Dong-Yun
authors.identifier: 0000-0002-7540-0522
authors.initials: DY
authors.lastname: Lee
authors.affiliation: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Hye Sun
authors.identifier: 0000-0002-3877-252X
authors.initials: HS
authors.lastname: Hyun
authors.affiliation: Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Rimm
authors.initials: R
authors.lastname: Huh
authors.affiliation: Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Dong-Kyu
authors.initials: DK
authors.lastname: Jin
authors.affiliation: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Duk-Kyung
authors.initials: DK
authors.lastname: Kim
authors.affiliation: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: Byung-Koo
authors.initials: BK
authors.lastname: Yoon
authors.affiliation: Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors.forename: DooSeok
authors.identifier: 0000-0002-5265-4749
authors.initials: D
authors.lastname: Choi
mesh_terms: D001827:Body Height; D002648:Child; D003270:Contraceptive Agents / Q000627:therapeutic use*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006130:Growth Disorders / Q000473:pathology; D006801:Humans; D008382:Marfan Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D003270:Contraceptive Agents; D004958:Estradiol
keywords: Estradiol Valerate; Height Control; Marfan Syndrome; Tall Stature
references.citation: Eur J Pediatr. 1990 Apr;149(7):452-6
references.pmid: 2140773
references.citation: Arch Dis Child. 1976 Mar;51(3):170-9
references.pmid: 952550
references.citation: Clin Orthop Relat Res. 1992 Apr;(277):251-61
references.pmid: 1555349
references.citation: Am J Med Genet. 1996 Apr 24;62(4):417-26
references.pmid: 8723076
references.citation: J Clin Endocrinol Metab. 1996 Mar;81(3):1206-16
references.pmid: 8772601
references.citation: Endocr Rev. 1998 Oct;19(5):540-58
references.pmid: 9793756
references.citation: J Pediatr. 2005 Nov;147(5):674-9
references.pmid: 16291362
references.citation: Lancet. 2005 Dec 3;366(9501):1965-76
references.pmid: 16325700
references.citation: Endocr Res. 2009;34(4):109-20
references.pmid: 19878071
references.citation: Clin Ther. 2012 Jan;34(1):37-55
references.pmid: 22169052
references.citation: Am J Med Genet. 2002 Apr 22;109(2):100-15
references.pmid: 11977157
references.citation: Acta Paediatr Scand. 1977 Mar;66(2):161-7
references.pmid: 842338
references.citation: Birth Defects Orig Artic Ser. 1977;13(3C):155-61
references.pmid: 196698
references.citation: Eur J Pediatr. 1979 Sep;132(1):37-41
references.pmid: 499254
references.citation: Pediatr Clin North Am. 1981 May;28(2):501-12
references.pmid: 7243375
references.citation: Arch Dis Child. 1985 Oct;60(10):932-5
references.pmid: 4062345
references.citation: Acta Paediatr Scand. 1988 Jul;77(4):537-41
references.pmid: 3394507
references.citation: J Clin Endocrinol. 1972 January;34:51-8
references.pmid: 12332922
references.citation: J Korean Med Sci. 2015 Jul;30(7):911-6
references.pmid: 26130954
references.citation: Nature. 1991 Jul 25;352(6333):337-9
references.pmid: 1852208